Detalhe da pesquisa
1.
Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen-mismatched donors.
Blood
; 136(13): 1499-1506, 2020 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32603426
2.
Clinical inertia in the treatment of heart failure: a major issue to tackle.
Heart Fail Rev
; 26(6): 1359-1370, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32474794
3.
Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia.
Blood
; 133(26): 2765-2775, 2019 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30862645
4.
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades.
Haematologica
; 106(6): 1599-1607, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32499241
5.
A phase II study of addition of pracinostat to a hypomethylating agent in patients with myelodysplastic syndromes who have not responded to previous hypomethylating agent therapy.
Br J Haematol
; 188(3): 404-412, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31468521
6.
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML.
Blood
; 131(13): 1415-1424, 2018 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29348128
7.
Combination trial of duvelisib (IPI-145) with rituximab or bendamustine/rituximab in patients with non-Hodgkin lymphoma or chronic lymphocytic leukemia.
Am J Hematol
; 94(12): 1325-1334, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31490009
8.
Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher-risk myelodysplastic syndromes.
Cancer
; 123(6): 994-1002, 2017 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28094841
9.
Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality.
Blood
; 124(2): 287-95, 2014 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24797298
10.
Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Cancer
; 121(20): 3709-16, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26207349
11.
Multi-centre validation of the prognostic value of the haematopoietic cell transplantation- specific comorbidity index among recipient of allogeneic haematopoietic cell transplantation.
Br J Haematol
; 170(4): 574-83, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25945807
12.
Pevonedistat (MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study.
Br J Haematol
; 169(4): 534-43, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25733005
13.
REVEAL-1, a phase 2 dose regimen optimization study of vosaroxin in older poor-risk patients with previously untreated acute myeloid leukaemia.
Br J Haematol
; 168(6): 796-805, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25403830
14.
A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemia.
Haematologica
; 100(2): 231-7, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25381131
15.
A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation.
Haematologica
; 99(10): 1624-31, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25085357
16.
ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study.
Target Oncol
; 19(3): 321-332, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38683495
17.
Role of the saturated nonesterified fatty acid palmitate in beta cell dysfunction.
J Proteome Res
; 12(1): 347-62, 2013 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23170928
18.
Cardio-renal-metabolic syndrome: clinical features and dapagliflozin eligibility in a real-world heart failure cohort.
ESC Heart Fail
; 10(4): 2269-2280, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37095712
19.
A Phase I Study of Pelabresib (CPI-0610), a Small-Molecule Inhibitor of BET Proteins, in Patients with Relapsed or Refractory Lymphoma.
Cancer Res Commun
; 2(8): 795-805, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36923307
20.
Safety and Efficacy of a DNA Oligonucleotide Therapy in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Clin Lymphoma Myeloma Leuk
; 22(1): 52-59, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34454850